Variant report

Variant	nsv598678
Chromosome Location	chr5:75614737-75628413
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr5:75615436-75615941	K562	blood:	n/a	n/a
2	ATF1	chr5:75615481-75615873	K562	blood:	n/a	n/a
3	ATF1	chr5:75627072-75627286	K562	blood:	n/a	n/a
4	BACH1	chr5:75622537-75622692	H1-hESC	embryonic stem cell:	n/a	n/a
5	BHLHE40	chr5:75615266-75615927	K562	blood:	n/a	n/a
6	CCNT2	chr5:75615311-75615956	K562	blood:	n/a	chr5:75615724-75615744
7	CCNT2	chr5:75627056-75627331	K562	blood:	n/a	n/a
8	CEBPB	chr5:75625787-75626036	K562	blood:	n/a	n/a
9	CEBPB	chr5:75615490-75615945	K562	blood:	n/a	n/a
10	CEBPB	chr5:75625473-75625525	H1-hESC	embryonic stem cell:	n/a	n/a
11	CEBPB	chr5:75625808-75626112	HepG2	liver:	n/a	n/a
12	CEBPD	chr5:75615481-75616067	K562	blood:	n/a	n/a
13	CEBPD	chr5:75615314-75616027	K562	blood:	n/a	n/a
14	CTCF	chr5:75617929-75618027	Kidney_OC	kidney:	n/a	n/a
15	CTCF	chr5:75628154-75628200	Fibrobl	skin:	n/a	n/a
16	CTCF	chr5:75627300-75627450	Caco-2	colon:	n/a	n/a
17	CTCF	chr5:75617011-75617077	LNCaP	prostate:	n/a	n/a
18	CTCF	chr5:75627000-75627150	GM12873	blood:	n/a	n/a
19	CTCF	chr5:75624693-75624718	Fibrobl	skin:	n/a	n/a
20	CTCF	chr5:75626940-75627090	HepG2	liver:	n/a	n/a
21	CUX1	chr5:75616285-75616349	K562	blood:	n/a	n/a
22	CUX1	chr5:75615535-75615962	K562	blood:	n/a	n/a
23	CUX1	chr5:75616568-75616575	K562	blood:	n/a	n/a
24	E2F4	chr5:75625997-75626153	MCF10A-Er-Src	breast:	n/a	n/a
25	E2F6	chr5:75626892-75627231	H1-hESC	embryonic stem cell:	n/a	n/a
26	EP300	chr5:75627048-75627347	K562	blood:	n/a	n/a
27	EP300	chr5:75615273-75616184	K562	blood:	n/a	chr5:75615979-75615993 chr5:75615981-75615995 chr5:75615975-75615989 chr5:75615980-75615994 chr5:75615368-75615378
28	EP300	chr5:75615557-75615859	K562	blood:	n/a	n/a
29	FOXA1	chr5:75624150-75624427	T-47D	breast:	n/a	n/a
30	FOXP2	chr5:75621422-75622054	SK-N-MC	brain:	n/a	n/a
31	GATA1	chr5:75615250-75616148	PBDE	blood:	n/a	chr5:75615726-75615735 chr5:75615725-75615735 chr5:75615722-75615738 chr5:75615773-75615790 chr5:75615727-75615744
32	GATA1	chr5:75614980-75617386	K562	blood:	n/a	chr5:75615726-75615735 chr5:75615725-75615735 chr5:75615722-75615738 chr5:75615773-75615790 chr5:75615727-75615744
33	GATA1	chr5:75615534-75615954	PBDEFetal	blood:	n/a	chr5:75615726-75615735 chr5:75615725-75615735 chr5:75615722-75615738 chr5:75615773-75615790 chr5:75615727-75615744
34	GATA2	chr5:75627010-75627307	K562	blood:	n/a	n/a
35	GATA2	chr5:75615305-75616070	K562	blood:	n/a	chr5:75615726-75615735 chr5:75615725-75615735 chr5:75615722-75615738 chr5:75615773-75615790 chr5:75615727-75615744
36	GATA2	chr5:75623724-75624263	SH-SY5Y	brain:	n/a	n/a
37	GATA2	chr5:75615444-75615926	K562	blood:	n/a	chr5:75615726-75615735 chr5:75615725-75615735 chr5:75615722-75615738 chr5:75615773-75615790 chr5:75615727-75615744
38	GATA3	chr5:75623735-75624343	T-47D	breast:	n/a	n/a
39	GATA3	chr5:75623808-75624365	MCF-7	breast:	n/a	n/a
40	GATA3	chr5:75623713-75624475	T-47D	breast:	n/a	n/a
41	HEY1	chr5:75627854-75628181	HepG2	liver:	n/a	n/a
42	HMGN3	chr5:75615429-75615854	K562	blood:	n/a	n/a
43	HNF4A	chr5:75627930-75628278	HepG2	liver:	n/a	chr5:75628109-75628124
44	HNF4A	chr5:75627969-75628272	HepG2	liver:	n/a	chr5:75628109-75628124
45	HNF4G	chr5:75627829-75628206	HepG2	liver:	n/a	n/a
46	HNF4G	chr5:75627841-75628220	HepG2	liver:	n/a	n/a
47	IRF1	chr5:75615399-75615918	K562	blood:	n/a	chr5:75615714-75615728 chr5:75615420-75615434 chr5:75615714-75615734 chr5:75615714-75615727
48	IRF1	chr5:75615396-75615982	K562	blood:	n/a	chr5:75615714-75615728 chr5:75615420-75615434 chr5:75615714-75615734 chr5:75615714-75615727
49	IRF1	chr5:75615448-75615835	K562	blood:	n/a	chr5:75615714-75615728 chr5:75615714-75615734 chr5:75615714-75615727
50	JUN	chr5:75615392-75615920	K562	blood:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:75621618-75621668	HEEpiC	esophagus:	n/a
2	chr5:75621618-75621668	HIPEpiC	eye:	n/a
3	chr5:75621618-75621668	Caco-2	colon:	n/a
4	chr5:75621618-75621668	T-47D	breast:	n/a
5	chr5:75621618-75621668	ProgFib	skin:	n/a
6	chr5:75621618-75621668	HNPCEpiC	eye:	n/a
7	chr5:75621618-75621668	Hepatocyte	liver:	n/a
8	chr5:75621618-75621668	MCF10A-Er-Src	breast:	n/a
9	chr5:75621618-75621668	SK-N-SH_RA	brain:	n/a
10	chr5:75621618-75621668	HRE	kidney:	n/a
11	chr5:75621618-75621668	GM19239	blood:	n/a
12	chr5:75621618-75621668	HPAEpiC	pulmonary alveolar:	n/a
13	chr5:75621618-75621668	PANC-1	pancreas:	n/a
14	chr5:75621618-75621668	AoSMC	blood vessel:	n/a
15	chr5:75621618-75621668	HEK293	kidney:	embryo
16	chr5:75621618-75621668	HRCEpiC	kidney:	n/a
17	chr5:75621618-75621668	RPTEC	kidney:	n/a
18	chr5:75621618-75621668	IMR90	lung:	fetal
19	chr5:75621618-75621668	HCM	heart:	n/a
20	chr5:75621618-75621668	AG09309	skin:	n/a
21	chr5:75621618-75621668	SAEC	small airway:	n/a
22	chr5:75621618-75621668	AG10803	skin:	n/a
23	chr5:75621618-75621668	CMK	blood:	n/a
24	chr5:75621618-75621668	K562	blood:	n/a
25	chr5:75621618-75621668	NB4	blood:	n/a
26	chr5:75621618-75621668	HMEC	breast:	n/a
27	chr5:75621618-75621668	HL-60	blood:	n/a
28	chr5:75621618-75621668	NHBE	bronchial:	n/a
29	chr5:75621618-75621668	HUVEC	blood vessel:	n/a
30	chr5:75621618-75621668	NHDF-neo	bronchial:	n/a
31	chr5:75621618-75621668	HCPEpiC	choroid plexus:	n/a
32	chr5:75621618-75621668	GM12892	blood:	n/a
33	chr5:75621618-75621668	NT2-D1	testis:	n/a
34	chr5:75621618-75621668	AG09319	gingival:	n/a
35	chr5:75621618-75621668	SK-N-MC	brain:	n/a
36	chr5:75621618-75621668	H1-hESC	embryonic stem cell:	embryo
37	chr5:75621618-75621668	HAEpiC	amniotic membrane:	n/a
38	chr5:75621618-75621668	GM12891	blood:	n/a
39	chr5:75621618-75621668	A549	lung:	n/a
40	chr5:75621618-75621668	BJ	skin:	n/a
41	chr5:75621618-75621668	HCF	heart:	n/a
42	chr5:75621618-75621668	PrEC	prostate:	n/a
43	chr5:75621618-75621668	GM12878	blood:	n/a
44	chr5:75621618-75621668	SKMC	muscle:	n/a
45	chr5:75621618-75621668	HepG2	liver:	n/a
46	chr5:75621618-75621668	BE2_C	brain:	n/a
47	chr5:75621618-75621668	GM06990	blood:	n/a
48	chr5:75621618-75621668	ECC-1	luminal epithelium:	n/a
49	chr5:75621618-75621668	Jurkat	blood:	n/a
50	chr5:75621618-75621668	MCF-7	breast:	n/a

No.	Distal block	Cell Line	Cell type
1	chr5:75613788..75615569-chr5:75621673..75623658,3	K562	blood:
2	chr5:75624448..75626842-chr5:75628180..75631008,2	K562	blood:
3	chr5:75613788..75615569-chr5:75621673..75623658,3	K562	blood:
4	chr5:75624448..75626842-chr5:75628180..75631008,2	K562	blood:
5	chr5:75620579..75623947-chr5:75630745..75632949,3	K562	blood:
6	chr5:75621687..75623947-chr5:75631428..75633046,3	K562	blood:
7	chr5:75608362..75610873-chr5:75614139..75616859,2	K562	blood:
8	chr5:75620781..75623735-chr5:75631052..75633279,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-IQGAP2-1	chr5:75627662-75629781	ENSG00000266045.1

Variant related genes	Relation type
ENSG00000266045	TF binding region
ENSG00000266045	CpG island

Extended variants
information (count: 549 )
Associated
traits (count: 88 )

Variant overlapped rSNPs/rCNVs (count:549 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs10062226	chr5:75614737-75614738	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs556719376	chr5:75614784-75614785	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs572639718	chr5:75614797-75614798	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs541244591	chr5:75614816-75614817	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs573780950	chr5:75614857-75614858	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs2913255	chr5:75614859-75614860	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs551004357	chr5:75614868-75614869	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs116636753	chr5:75614904-75614905	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs11750113	chr5:75614962-75614963	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs562473343	chr5:75614973-75614974	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs531293764	chr5:75615022-75615023	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs114050577	chr5:75615041-75615042	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs12055200	chr5:75615056-75615057	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs144579342	chr5:75615063-75615064	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs138680540	chr5:75615074-75615075	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs397884624	chr5:75615075-75615076	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs527507143	chr5:75615084-75615085	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs11341644	chr5:75615085-75615086	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs200468752	chr5:75615086-75615087	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs547256526	chr5:75615098-75615099	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs570276028	chr5:75615100-75615101	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs375275772	chr5:75615101-75615102	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs148458990	chr5:75615106-75615107	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs2012412	chr5:75615107-75615108	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs573297250	chr5:75615126-75615127	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs535471402	chr5:75615185-75615186	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs566078354	chr5:75615200-75615201	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs566227332	chr5:75615207-75615208	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs142600654	chr5:75615224-75615225	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs151280913	chr5:75615230-75615231	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs545416999	chr5:75615242-75615243	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs578183811	chr5:75615244-75615245	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs78814048	chr5:75615276-75615277	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs556285928	chr5:75615277-75615278	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs141631317	chr5:75615333-75615334	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs114172863	chr5:75615334-75615335	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs187746931	chr5:75615345-75615346	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs369248864	chr5:75615348-75615349	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs192052820	chr5:75615349-75615350	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs541289702	chr5:75615361-75615362	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs369211358	chr5:75615398-75615399	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs182758891	chr5:75615404-75615405	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs7733948	chr5:75615453-75615454	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
44	rs1469387	chr5:75615456-75615457	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs187476026	chr5:75615531-75615532	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs79030328	chr5:75615544-75615545	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs145389868	chr5:75615549-75615550	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs566037871	chr5:75615557-75615558	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs535011442	chr5:75615564-75615565	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs552064463	chr5:75615610-75615611	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:88)

Disease	PMID	Source
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Metanephric adenoma	20802469	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Cancer	16751803	CNVD
Intellectual disability	22102821	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Breast cancer	17603634	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Melanoma	18172304	CNVD
Glioma	20126413	CNVD
Breast cancer	22032731	CNVD
Prostate cancer	21965145	CNVD
Spinal muscular atrophy	21762474	CNVD
Esophageal cancer	20955586	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Ovarian cancer	20844748	CNVD
Breast cancer	17393978	CNVD
Cancer	21359685	CNVD
Non-small cell lung cancer	21829676	CNVD
adenomatous polyposis	22470819	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Breast cancer	21858162	CNVD
Hepatocellular carcinoma	16750200	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Breast cancer	19602461	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Retinoblastoma	22278416	CNVD
Bipolar disorder	18458673	CNVD
Thyroid cancer	19087340	CNVD
Breast cancer	21785460	CNVD
Merkel cell carcinoma	19020549	CNVD
Squamous cell cancer	20885788	CNVD
Neurodevelopmental disorder	22521361	CNVD
Prostate cancer	18632612	CNVD
Spinal muscular atrophy	15981080	CNVD
Spinal muscular atrophy	18839960	CNVD
Spinal muscular atrophy	19716110	CNVD
Glioblastoma multiforme	22286061	CNVD
craniofacial dysmorphism	21918468	CNVD
Multiple myeloma	16616336	CNVD
Prostate cancer	16461572	CNVD
Breast cancer	17133270	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Acute myeloid leukemia	20729466	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Ovarian cancer	21720365	CNVD
Acute myeloid leukemia	21251322	CNVD
Myelofibrosis	22110671	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Schizophrenia	23813976	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	21364760	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:355 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:75609600-75615200	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
2	chr5:75613600-75615200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
3	chr5:75613600-75615400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
4	chr5:75613600-75617800	Enhancers	Primary hematopoietic stem cells	blood
5	chr5:75614200-75615400	Enhancers	Primary hematopoietic stem cells short term culture	blood
6	chr5:75614400-75615200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
7	chr5:75614400-75615600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
8	chr5:75614600-75615200	Enhancers	K562	blood
9	chr5:75615000-75615200	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
10	chr5:75615200-75615600	Enhancers	Fetal Adrenal Gland	Adrenal Gland
11	chr5:75615200-75615800	Enhancers	Primary monocytes fromperipheralblood	blood
12	chr5:75615200-75615800	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
13	chr5:75615200-75616200	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
14	chr5:75615200-75616200	Flanking Active TSS	K562	blood
15	chr5:75615400-75615600	Bivalent Enhancer	Monocytes-CD14+_RO01746	blood
16	chr5:75615400-75615800	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
17	chr5:75615400-75616000	Enhancers	Primary T cells from cord blood	blood
18	chr5:75615400-75616000	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
19	chr5:75615600-75615800	Enhancers	Monocytes-CD14+_RO01746	blood
20	chr5:75615800-75616000	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
21	chr5:75615800-75616800	Weak transcription	Monocytes-CD14+_RO01746	blood
22	chr5:75615800-75617400	Enhancers	Primary hematopoietic stem cells short term culture	blood
23	chr5:75615800-75621000	Weak transcription	Primary monocytes fromperipheralblood	blood
24	chr5:75616000-75617800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
25	chr5:75616000-75620000	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
26	chr5:75616000-75620800	Weak transcription	Primary T cells from cord blood	blood
27	chr5:75616200-75617000	Enhancers	K562	blood
28	chr5:75616200-75617400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
29	chr5:75617000-75617200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
30	chr5:75617200-75618400	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
31	chr5:75617400-75620600	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
32	chr5:75617400-75621000	Weak transcription	Primary hematopoietic stem cells short term culture	blood
33	chr5:75617800-75620600	Weak transcription	Primary hematopoietic stem cells	blood
34	chr5:75617800-75620600	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
35	chr5:75618400-75618800	ZNF genes & repeats	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
36	chr5:75618800-75620800	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
37	chr5:75620000-75625200	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
38	chr5:75620200-75621200	Enhancers	Primary T helper naive cells from peripheral blood	blood
39	chr5:75620200-75621200	Enhancers	Primary T killer memory cells from peripheral blood	blood
40	chr5:75620200-75621400	Enhancers	Primary T cells fromperipheralblood	blood
41	chr5:75620200-75621400	Enhancers	Primary T helper cells PMA-I stimulated	--
42	chr5:75620200-75621800	Enhancers	Primary T killer naive cells fromperipheralblood	blood
43	chr5:75620200-75624600	Enhancers	Fetal Adrenal Gland	Adrenal Gland
44	chr5:75620400-75621600	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
45	chr5:75620400-75623400	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
46	chr5:75620400-75629400	Enhancers	Primary T helper cells fromperipheralblood	blood
47	chr5:75620600-75621400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
48	chr5:75620600-75627000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
49	chr5:75620600-75629600	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
50	chr5:75620600-75630400	Enhancers	Primary hematopoietic stem cells	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links